Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice
Open Access
- 17 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 12, 153
- https://doi.org/10.3389/fnagi.2020.00153
Abstract
Postmenopausal women have a higher incidence of stroke compared to the age-matched males, and the estrogen was thought to be the main cause of such difference. However, estrogen replacement therapy for the prevention of postmenopausal stroke shows controversial results and is widely disputed because of its serious side effects after chronic administration. Genistein (Gen), a natural phytestrogen with fewer side effects, has a protective effect against cerebral ischemia damage. However, whether Gen could effectively prevent postmenopausal stroke has not been elucidated. In the current study, reproductively senescent mice were treated with Gen (10 mg/kg) for 2 weeks before having transient cerebral ischemia insults. Neurological scores, infarct volumes, and cell apoptosis were evaluated 24 h after reperfusion. The levels of inflammatory factors and nod-like receptor protein 3 (NLRP3) inflammasome-related proteins were also examined. The results showed that Gen treatment reduced infarct volumes, improved neurological scores, attenuated apoptosis, and decreased inflammatory factor release. The expression of NLRP3 inflammasome-related proteins in microglia was downregulated by Gen. However, the overexpression of NLRP3 in microglia abrogated the Gen-induced inhibition of inflammatory factor release and reversed the neuroprotective effect of Gen. Taken together, the results suggest that Gen treatment could attenuate the acute injury induced by cerebral ischemia in reproductively senescent mice via the inhibition of the NLRP3 inflammasome in microglia, indicating that Gen could be a candidate drug for the treatment of stroke in postmenopausal women.This publication has 43 references indexed in Scilit:
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeCell Death & Disease, 2013
- Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trialsClimacteric, 2012
- Neuroprotective Effects of Genistein in Mongolian Gerbils: Estrogen Receptor–β InvolvementJournal of Pharmacological Sciences, 2010
- Soy Consumption Reduces Risk of Ischemic Stroke: A Case-Control Study in Southern ChinaNeuroepidemiology, 2009
- Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseasesFrontiers in Neuroendocrinology, 2008
- Association of Dietary Intake of Soy, Beans, and Isoflavones With Risk of Cerebral and Myocardial Infarctions in Japanese PopulationsCirculation, 2007
- The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer CellsOnline Journal of Public Health Informatics, 2004
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseThe New England Journal of Medicine, 1996
- Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in RatsStroke, 1995